Jan Albert NicolaasJ.A.N.GrootJan Albert NicolaasJ.A.N., Leonore TenL.T.BokumLeonore TenL.T., Hubertus Laurentius Antonius van denH.L.A.OeverHubertus Laurentius Antonius van denH.L.A., Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI: 10.1186/s40560-018-0329-1, ISSN2052-0492, PMID: 30214811, PMCID: PMC6131849 [dostęp 2020-04-28].
AnkaviparA.SaprungruangAnkaviparA. i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI: 10.1016/j.ipej.2018.07.007, ISSN0972-6292, PMID: 30036649, PMCID: PMC6198685 [dostęp 2020-04-28].
Peter J.P.J.SchwartzPeter J.P.J., Raymond L.R.L.WoosleyRaymond L.R.L., Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI: 10.1016/j.jacc.2015.12.063, ISSN1558-3597, PMID: 27150690 [dostęp 2020-04-28].
PascalP.ChamperouxPascalP. i inni, Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres, „British Journal of Pharmacology”, 144 (3), 2005, s. 376–385, DOI: 10.1038/sj.bjp.0706070, ISSN0007-1188 [dostęp 2020-04-28].
T.L.T.L.LenzT.L.T.L., D.E.D.E.HillemanD.E.D.E., Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI: 10.1592/phco.20.9.776.35208, ISSN0277-0008, PMID: 10907968 [dostęp 2020-04-28].
TaoT.YangTaoT. i inni, Screening for Acute IKr Block is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current, „Circulation”, 130 (3), 2014, s. 224–234, DOI: 10.1161/circulationaha.113.007765, ISSN0009-7322 [dostęp 2020-04-28].
Yee GuanY.G.YapYee GuanY.G., A. JohnA.J.CammA. JohnA.J., Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI: 10.1136/heart.89.11.1363, ISSN1468-201X, PMID: 14594906, PMCID: PMC1767957 [dostęp 2020-04-28].
JinuJ.JohnJinuJ. i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI: 10.4061/2010/524764, ISSN2090-0597, PMID: 21253542, PMCID: PMC3021856 [dostęp 2020-04-28].
Simon H.L.S.H.L.ThomasSimon H.L.S.H.L., Elijah R.E.R.BehrElijah R.E.R., Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI: 10.1111/bcp.12726, ISSN1365-2125, PMID: 26183037, PMCID: PMC4767204 [dostęp 2020-04-28].
KenjiK.HoshinoKenjiK. i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI: 10.1111/j.1442-200X.2006.02177.x, ISSN1328-8067, PMID: 16635167 [dostęp 2020-04-28].
Silvia G.S.G.PrioriSilvia G.S.G. i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI: 10.1093/europace/euv319, ISSN1532-2092, PMID: 26318695 [dostęp 2020-04-28].
Jan Albert NicolaasJ.A.N.GrootJan Albert NicolaasJ.A.N., Leonore TenL.T.BokumLeonore TenL.T., Hubertus Laurentius Antonius van denH.L.A.OeverHubertus Laurentius Antonius van denH.L.A., Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI: 10.1186/s40560-018-0329-1, ISSN2052-0492, PMID: 30214811, PMCID: PMC6131849 [dostęp 2020-04-28].
F.F.DessertenneF.F., [Ventricular tachycardia with 2 variable opposing foci], „Archives Des Maladies Du Coeur Et Des Vaisseaux”, 59 (2), 1966, s. 263–272, ISSN0003-9683, PMID: 4956181 [dostęp 2020-04-28].
AnkaviparA.SaprungruangAnkaviparA. i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI: 10.1016/j.ipej.2018.07.007, ISSN0972-6292, PMID: 30036649, PMCID: PMC6198685 [dostęp 2020-04-28].
Peter J.P.J.SchwartzPeter J.P.J., Raymond L.R.L.WoosleyRaymond L.R.L., Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI: 10.1016/j.jacc.2015.12.063, ISSN1558-3597, PMID: 27150690 [dostęp 2020-04-28].
T.L.T.L.LenzT.L.T.L., D.E.D.E.HillemanD.E.D.E., Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI: 10.1592/phco.20.9.776.35208, ISSN0277-0008, PMID: 10907968 [dostęp 2020-04-28].
Yee GuanY.G.YapYee GuanY.G., A. JohnA.J.CammA. JohnA.J., Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI: 10.1136/heart.89.11.1363, ISSN1468-201X, PMID: 14594906, PMCID: PMC1767957 [dostęp 2020-04-28].
JinuJ.JohnJinuJ. i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI: 10.4061/2010/524764, ISSN2090-0597, PMID: 21253542, PMCID: PMC3021856 [dostęp 2020-04-28].
Simon H.L.S.H.L.ThomasSimon H.L.S.H.L., Elijah R.E.R.BehrElijah R.E.R., Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI: 10.1111/bcp.12726, ISSN1365-2125, PMID: 26183037, PMCID: PMC4767204 [dostęp 2020-04-28].
KenjiK.HoshinoKenjiK. i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI: 10.1111/j.1442-200X.2006.02177.x, ISSN1328-8067, PMID: 16635167 [dostęp 2020-04-28].
Silvia G.S.G.PrioriSilvia G.S.G. i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI: 10.1093/europace/euv319, ISSN1532-2092, PMID: 26318695 [dostęp 2020-04-28].
PiotrP.ThorPiotrP., Podstawy patofizjologii człowieka, Kraków: Fundacja Zdrowia Publicznego - Uniwersyteckie Wydawnictwo Medyczne "Vesalius", 2007, s. 305-307, ISBN 978-83-85688-78-5, OCLC750115269 [dostęp 2020-04-28].
Jan Albert NicolaasJ.A.N.GrootJan Albert NicolaasJ.A.N., Leonore TenL.T.BokumLeonore TenL.T., Hubertus Laurentius Antonius van denH.L.A.OeverHubertus Laurentius Antonius van denH.L.A., Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI: 10.1186/s40560-018-0329-1, ISSN2052-0492, PMID: 30214811, PMCID: PMC6131849 [dostęp 2020-04-28].
F.F.DessertenneF.F., [Ventricular tachycardia with 2 variable opposing foci], „Archives Des Maladies Du Coeur Et Des Vaisseaux”, 59 (2), 1966, s. 263–272, ISSN0003-9683, PMID: 4956181 [dostęp 2020-04-28].
AnkaviparA.SaprungruangAnkaviparA. i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI: 10.1016/j.ipej.2018.07.007, ISSN0972-6292, PMID: 30036649, PMCID: PMC6198685 [dostęp 2020-04-28].
Peter J.P.J.SchwartzPeter J.P.J., Raymond L.R.L.WoosleyRaymond L.R.L., Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI: 10.1016/j.jacc.2015.12.063, ISSN1558-3597, PMID: 27150690 [dostęp 2020-04-28].
PascalP.ChamperouxPascalP. i inni, Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres, „British Journal of Pharmacology”, 144 (3), 2005, s. 376–385, DOI: 10.1038/sj.bjp.0706070, ISSN0007-1188 [dostęp 2020-04-28].
Sanoski i inni, Davis's drug guide for nurses, Fourteenth edition, Philadelphia, ISBN 978-0-8036-4085-6, OCLC881473728 [dostęp 2020-04-28]. Brak numerów stron w książce
T.L.T.L.LenzT.L.T.L., D.E.D.E.HillemanD.E.D.E., Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI: 10.1592/phco.20.9.776.35208, ISSN0277-0008, PMID: 10907968 [dostęp 2020-04-28].
TaoT.YangTaoT. i inni, Screening for Acute IKr Block is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current, „Circulation”, 130 (3), 2014, s. 224–234, DOI: 10.1161/circulationaha.113.007765, ISSN0009-7322 [dostęp 2020-04-28].
Yee GuanY.G.YapYee GuanY.G., A. JohnA.J.CammA. JohnA.J., Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI: 10.1136/heart.89.11.1363, ISSN1468-201X, PMID: 14594906, PMCID: PMC1767957 [dostęp 2020-04-28].
JinuJ.JohnJinuJ. i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI: 10.4061/2010/524764, ISSN2090-0597, PMID: 21253542, PMCID: PMC3021856 [dostęp 2020-04-28].
Simon H.L.S.H.L.ThomasSimon H.L.S.H.L., Elijah R.E.R.BehrElijah R.E.R., Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI: 10.1111/bcp.12726, ISSN1365-2125, PMID: 26183037, PMCID: PMC4767204 [dostęp 2020-04-28].
KenjiK.HoshinoKenjiK. i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI: 10.1111/j.1442-200X.2006.02177.x, ISSN1328-8067, PMID: 16635167 [dostęp 2020-04-28].
Silvia G.S.G.PrioriSilvia G.S.G. i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI: 10.1093/europace/euv319, ISSN1532-2092, PMID: 26318695 [dostęp 2020-04-28].